CL2012002195A1 - Composicion inmunogénica que comprende una mezcla de conjugados de polisacaridos-proteina multivalente que consiste en polisacáridos capsulares de streptococcus pneumoniae; metodo para inducir una respuesta inmune a un polisacarido capsular de streptococcus pneumoniae. - Google Patents

Composicion inmunogénica que comprende una mezcla de conjugados de polisacaridos-proteina multivalente que consiste en polisacáridos capsulares de streptococcus pneumoniae; metodo para inducir una respuesta inmune a un polisacarido capsular de streptococcus pneumoniae.

Info

Publication number
CL2012002195A1
CL2012002195A1 CL2012002195A CL2012002195A CL2012002195A1 CL 2012002195 A1 CL2012002195 A1 CL 2012002195A1 CL 2012002195 A CL2012002195 A CL 2012002195A CL 2012002195 A CL2012002195 A CL 2012002195A CL 2012002195 A1 CL2012002195 A1 CL 2012002195A1
Authority
CL
Chile
Prior art keywords
streptococcus pneumoniae
polysaccharide
capsular
induce
mixture
Prior art date
Application number
CL2012002195A
Other languages
English (en)
Inventor
Michael J Caufield
Patrick L Ahl
Jeffrey T Blue
Jayme L Cannon
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of CL2012002195A1 publication Critical patent/CL2012002195A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composición inmunogénica que comprende una mezcla de conjugados de polisacáridos-proteína multivalente que consiste en polisacáridos capsulares de Streptococcus Pneumoniae; método para inducir una respuesta inmune a un polisacárido capsular de Streptococcus Pneumoniae.
CL2012002195A 2010-02-09 2012-08-07 Composicion inmunogénica que comprende una mezcla de conjugados de polisacaridos-proteina multivalente que consiste en polisacáridos capsulares de streptococcus pneumoniae; metodo para inducir una respuesta inmune a un polisacarido capsular de streptococcus pneumoniae. CL2012002195A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30272610P 2010-02-09 2010-02-09

Publications (1)

Publication Number Publication Date
CL2012002195A1 true CL2012002195A1 (es) 2012-11-30

Family

ID=44353903

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012002195A CL2012002195A1 (es) 2010-02-09 2012-08-07 Composicion inmunogénica que comprende una mezcla de conjugados de polisacaridos-proteina multivalente que consiste en polisacáridos capsulares de streptococcus pneumoniae; metodo para inducir una respuesta inmune a un polisacarido capsular de streptococcus pneumoniae.

Country Status (24)

Country Link
US (2) US20120301502A1 (es)
EP (1) EP2533805A4 (es)
JP (2) JP2013518891A (es)
KR (1) KR101538535B1 (es)
CN (1) CN102858365A (es)
AR (2) AR080122A1 (es)
AU (1) AU2011216095B2 (es)
BR (1) BR112012019757B8 (es)
CA (1) CA2788680C (es)
CL (1) CL2012002195A1 (es)
EC (1) ECSP12012100A (es)
IL (1) IL221283A0 (es)
MA (1) MA34051B1 (es)
MX (1) MX2012009206A (es)
MY (1) MY159984A (es)
NZ (1) NZ601711A (es)
PE (1) PE20121698A1 (es)
RU (1) RU2012138368A (es)
SG (2) SG183199A1 (es)
TN (1) TN2012000377A1 (es)
TW (1) TW201136603A (es)
UA (1) UA106115C2 (es)
WO (1) WO2011100151A1 (es)
ZA (1) ZA201205737B (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101180079B (zh) 2005-04-08 2012-07-18 惠氏公司 多价肺炎球菌多糖-蛋白质缀合物组合物
PE20110072A1 (es) 2005-06-27 2011-02-04 Glaxosmithkline Biolog Sa Composicion inmunogenica
EP2066344B2 (en) * 2006-09-07 2016-06-29 GlaxoSmithKline Biologicals S.A. Inactivated Poliovirus combination vaccine
HRP20231631T1 (hr) 2011-04-22 2024-03-15 Wyeth Llc Pripravci koji se odnose na mutantni toksin iz bakterije clostridium difficile i odgovarajući postupci
WO2013078102A1 (en) * 2011-11-23 2013-05-30 Merck Sharp & Dohme Corp. Method for preparation of aluminum hydroxyphosphate adjuvant
KR102057217B1 (ko) * 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
US20140193451A1 (en) * 2012-10-17 2014-07-10 Glaxosmithkline Biologicals Sa Immunogenic composition
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
KR20140075196A (ko) 2012-12-11 2014-06-19 에스케이케미칼주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
KR20140075201A (ko) * 2012-12-11 2014-06-19 에스케이케미칼주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
CN103495161B (zh) * 2013-10-08 2019-06-18 江苏康泰生物医学技术有限公司 一种多元肺炎球菌荚膜多糖-蛋白质结合物的混合物及其制备方法
TWI586363B (zh) * 2013-10-30 2017-06-11 Sk化學公司 多價肺炎球菌多醣－蛋白質共軛物組成物
BR122023022294A2 (pt) 2014-01-21 2023-12-12 Pfizer Inc. Uso de uma composição imunogênica que compreende um conjugado imunogênico compreendendo um polissacarídeo capsular isolado de streptococcus pneumoniae do sorotipo 15b
KR102099741B1 (ko) 2014-01-21 2020-04-10 화이자 인코포레이티드 스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 및 그의 접합체
US11160855B2 (en) 2014-01-21 2021-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
US9492559B2 (en) * 2014-01-21 2016-11-15 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
JP2017505792A (ja) * 2014-02-14 2017-02-23 ファイザー・インク 免疫原性糖タンパク質コンジュゲート
CN103893751B (zh) * 2014-03-26 2016-04-20 天津康希诺生物技术有限公司 一种肺炎球菌多糖蛋白缀合疫苗及其制备方法
CN107847571A (zh) 2015-06-08 2018-03-27 印度血清研究所私人有限公司 用于改善多糖‑蛋白质缀合物及其获得的多价疫苗配制剂的吸附的方法
US11147863B2 (en) * 2015-06-23 2021-10-19 Biological E Limited Multivalent pneumococcal conjugate vaccine
SG10202005253TA (en) * 2015-07-21 2020-07-29 Pfizer Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
KR20200038339A (ko) * 2015-09-10 2020-04-10 인벤트프라이즈 엘엘씨 다가 vlp 접합체
WO2017173415A2 (en) * 2016-03-31 2017-10-05 Liffey Biotech Limited Saccharide-polypeptide conjugate compositions and methods of use thereof
AU2017293942A1 (en) * 2016-07-08 2019-02-28 Access To Advanced Health Institute West Nile virus vaccine and method of use thereof
CN109890415B (zh) 2016-08-05 2023-04-04 圣诺菲·帕斯图尔公司 多价肺炎球菌多糖-蛋白质缀合物组合物
EP3493837B1 (en) * 2016-08-05 2022-08-31 Sanofi Pasteur, Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
NZ752348A (en) 2016-09-30 2022-11-25 Biological E Ltd Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
WO2018080213A1 (ko) * 2016-10-28 2018-05-03 주식회사 엘지화학 향상된 IgG 역가를 갖는 다가면역원성 조성물 및 이의 용도
US11998599B2 (en) 2016-12-30 2024-06-04 Vaxcyte, Inc. Polypeptide-antigen conjugates with non-natural amino acids
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
US11197921B2 (en) 2017-01-31 2021-12-14 Merck Sharp & Dohme Corp. Methods for making polysaccharide-protein conjugates
KR102650073B1 (ko) 2017-01-31 2024-03-20 머크 샤프 앤드 돔 엘엘씨 스트렙토코커스 뉴모니아 혈청형 19f 유래의 협막 다당류 단백질 접합체의 제조 방법
US11246918B2 (en) 2017-02-03 2022-02-15 Eva Barbara Schadeck Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
US11400162B2 (en) 2017-02-24 2022-08-02 Merck Sharp & Dohme Llc Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
WO2018156465A1 (en) * 2017-02-24 2018-08-30 Merck Sharp & Dohme Corp. Polysaccharide-protein conjugates utilizing diphtheria toxin fragment b as a carrier
EP3585803A4 (en) * 2017-02-24 2020-11-11 Merck Sharp & Dohme Corp. PNEUMOCOCCIC CONJUGATE VACCINE FORMULATIONS
WO2018156491A1 (en) 2017-02-24 2018-08-30 Merck Sharp & Dohme Corp. Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugates
KR102634811B1 (ko) * 2017-06-10 2024-02-06 인벤트프라이즈 인크. 면역원성과 항원항체 결합성이 개선된 2가 또는 다가 접합체 다당류를 가진 다가 접합체 백신
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
WO2019036313A1 (en) * 2017-08-16 2019-02-21 Merck Sharp & Dohme Corp. CONJUGATED PNEUMOCOCCAL VACCINE FORMULATIONS
CN111065387B (zh) 2017-09-07 2023-08-25 默沙东有限责任公司 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
EP3678655A4 (en) * 2017-09-07 2021-05-05 Merck Sharp & Dohme Corp. ANTIPNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN POLYSACCHARIDE-CARRIER PROTEIN IMMUNOGENIC CONJUGATES
AU2018328037B2 (en) 2017-09-07 2024-03-07 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
CN116898959A (zh) 2017-09-07 2023-10-20 默沙东有限责任公司 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
JP2020533299A (ja) * 2017-09-07 2020-11-19 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． キャリアタンパク質へのコンジュゲーションのための肺炎球菌多糖の製剤方法
US11524076B2 (en) 2017-09-07 2022-12-13 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
JP7369123B2 (ja) 2017-12-06 2023-10-25 メルク・シャープ・アンド・ドーム・エルエルシー 肺炎球菌多糖類－タンパク質コンジュゲートを含む組成物およびその使用方法
MX2020008198A (es) * 2018-02-05 2020-09-22 Sanofi Pasteur Inc Composicion del conjugado proteina-polisacarido multivalente neumococica.
CA3087572A1 (en) 2018-02-05 2019-08-08 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
BR112020021296A2 (pt) 2018-04-18 2021-01-26 Sk Bioscience Co., Ltd. polissacarídeo capsular de streptococcus pneumoniae e conjugado imunogênico do mesmo
EP3788143B1 (en) 2018-04-30 2023-06-28 Merck Sharp & Dohme LLC Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide
EP3787673A4 (en) 2018-04-30 2022-04-27 Merck Sharp & Dohme Corp. METHODS FOR PRODUCING CAPSULAR CARRIER PROTEIN-POLYSACCHARIDE CONJUGATES OF STREPTOCOCCUS PNEUMONIAE
US20210236646A1 (en) * 2018-04-30 2021-08-05 Merck Sharp & Dohme Corp. Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
WO2019220304A1 (en) * 2018-05-14 2019-11-21 Tergene Biotech Pvt. Ltd. 15 valent pneumococcal polysaccharide conjugate vaccine
WO2020009462A1 (ko) * 2018-07-06 2020-01-09 주식회사 유바이오로직스 다가 폐렴구균 다당체-단백질 접합체를 포함하는 면역원성 조성물, 및 이를 포함하는 폐렴구균에 의한 질환 예방 백신
CN112673054A (zh) 2018-07-19 2021-04-16 葛兰素史密丝克莱恩生物有限公司 用于制备干燥多糖的方法
SG11202102007UA (en) * 2018-09-12 2021-03-30 Affinivax Inc Multivalent pneumococcal vaccines
MA54533A (fr) 2018-12-19 2022-03-30 Merck Sharp & Dohme Compositions comprenant des conjugués polysaccharide-protéine de streptococcus pneumoniae et leurs méthodes d'utilisation
US20220218812A1 (en) * 2019-06-05 2022-07-14 Merck Sharp & Dohme Corp. Methods of treating patients with an immunogenic composition that protects against s. pneumoniae serotype 29
CA3142692A1 (en) * 2019-06-05 2020-12-10 Merck Sharp & Dohme Corp. An immunogenic serotype 35b pneumococcal polysaccharide-protein conjugate and conjugation process for making the same
CN114364397B (zh) * 2019-07-18 2024-03-29 赛特瑞恩股份有限公司 含多价肺炎链球菌多糖-蛋白偶联物的免疫原性组合物、药物组合物及其用途
WO2021021729A1 (en) 2019-07-31 2021-02-04 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
KR20220102871A (ko) * 2021-01-14 2022-07-21 (주)셀트리온 다가 폐렴구균 다당류-단백질 접합체를 포함하는 면역원성 조성물
TW202245835A (zh) 2021-02-04 2022-12-01 美商默沙東有限責任公司 用於肺炎球菌結合物疫苗之奈米乳化液佐劑組合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
HU227613B1 (en) * 2000-06-29 2011-09-28 Glaxosmithkline Biolog Sa Vaccine composition
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
EP1781326A4 (en) * 2004-06-04 2009-01-14 Pharmexa Inc INDUCTION OF AN IMMUNE RESPONSE AGAINST STREPTOCOKE PENUMONIA POLYSACCHARIDES
CN1660881A (zh) * 2005-01-12 2005-08-31 北京万赛生物医药技术发展有限公司 新型的免疫刺激分子及其制备方法
CN101180079B (zh) * 2005-04-08 2012-07-18 惠氏公司 多价肺炎球菌多糖-蛋白质缀合物组合物
PE20110072A1 (es) * 2005-06-27 2011-02-04 Glaxosmithkline Biolog Sa Composicion inmunogenica
WO2007053781A2 (en) * 2005-11-01 2007-05-10 Novartis Ag Compositions with antigens adsorbed to calcium phosphate
NZ569168A (en) * 2005-12-22 2012-02-24 Glaxosmithkline Biolog Sa Streptococcus pneumoniae polysaccharide conjugate vaccine comprising 19F-DT conjugate
EA200801368A1 (ru) * 2005-12-23 2008-12-30 Глаксосмитклайн Байолоджикалс С.А. Конъюгатные вакцины
US20070253985A1 (en) * 2006-04-26 2007-11-01 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
MY150927A (en) * 2007-03-23 2014-03-14 Wyeth Corp Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides
KR101579947B1 (ko) * 2007-06-26 2015-12-28 글락소스미스클라인 바이오로지칼즈 에스.에이. 스트렙토코쿠스 뉴모니애 캡슐 다당류 컨쥬게이트를 포함하는 백신
CN101590224A (zh) * 2009-06-30 2009-12-02 广州精达医学科技有限公司 高效14价肺炎球菌结合疫苗

Also Published As

Publication number Publication date
AR116043A2 (es) 2021-03-25
TW201136603A (en) 2011-11-01
MY159984A (en) 2017-02-15
KR101538535B1 (ko) 2015-07-22
US20120301502A1 (en) 2012-11-29
US8192746B2 (en) 2012-06-05
CA2788680C (en) 2014-12-16
TN2012000377A1 (en) 2014-01-30
US20110195086A1 (en) 2011-08-11
NZ601711A (en) 2014-03-28
AU2011216095A1 (en) 2012-08-09
ZA201205737B (en) 2013-04-24
JP2014012720A (ja) 2014-01-23
RU2012138368A (ru) 2014-03-20
EP2533805A1 (en) 2012-12-19
WO2011100151A1 (en) 2011-08-18
IL221283A0 (en) 2012-10-31
BR112012019757B1 (pt) 2020-11-17
PE20121698A1 (es) 2012-12-11
AU2011216095B2 (en) 2013-07-18
CN102858365A (zh) 2013-01-02
UA106115C2 (uk) 2014-07-25
JP2013518891A (ja) 2013-05-23
BR112012019757A2 (pt) 2016-05-10
SG183199A1 (en) 2012-09-27
KR20120114345A (ko) 2012-10-16
ECSP12012100A (es) 2013-03-28
SG10201500350PA (en) 2015-03-30
CA2788680A1 (en) 2011-08-18
AR080122A1 (es) 2012-03-14
BR112012019757B8 (pt) 2023-04-25
MX2012009206A (es) 2012-08-23
EP2533805A4 (en) 2013-08-28
MA34051B1 (fr) 2013-03-05

Similar Documents

Publication Publication Date Title
CL2012002195A1 (es) Composicion inmunogénica que comprende una mezcla de conjugados de polisacaridos-proteina multivalente que consiste en polisacáridos capsulares de streptococcus pneumoniae; metodo para inducir una respuesta inmune a un polisacarido capsular de streptococcus pneumoniae.
HUS2200029I1 (hu) Konjugált burokszaccharid antigéneket tartalmazó immunogén készítmények és alkalmazásaik
ZA201206504B (en) Immunogenic composition comprising s. pneumoniae polysaccharides conjugates to carrier proteins
CY1121389T1 (el) Αντισωματα που δεσμευονται ειδικα με την α-τοξινη toy staphylococcus aureus και μεθοδοι χρησης
EP4286000A3 (en) Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
EA201290134A1 (ru) Система экспрессии
BR112014032091A2 (pt) composição imunogênica multivalente, e composição farmacêutica para induzir uma resposta imune a um conjugado de polissacarídeo capsular de streptococcus pneumoniae
SMT201500211B (it) Procedimento di coniugazione di polisaccaridi batterici a proteine di trasporto
WO2014197849A3 (en) Anti-c10orf54 antibodies and uses thereof
BR112015030514A2 (pt) Composições e métodos para conjugação de anticorpos ativáveis
EP3790591A4 (en) COMPOSITIONS AND METHODS RELATED TO ANTI-CD19 ANTIBODY-DRUG CONJUGATES
BR112016015835A2 (pt) Polissacarídeos capsulares de streptococcus pneumoniae e conjugados destes
MX352324B (es) Vacunas multivalentes de nanovehiculos sinteticos.
BR112012023055A2 (pt) amido-gelificante de ph sintonizável para uso em composições de produto destinado ao consumidor
MX2015002482A (es) Composicion inmunogenica.
BR112015008419A2 (pt) composição imunogênica, e, vacina
CL2012000744A1 (es) Proceso para preparar un conjugado de polisacáridos capsulares tipo 5 o tipo 8 de s. aureus y una molécula transportadora; conjugado de polisacáridos; y composición inmunogénica que lo comprende.
MX2016006001A (es) Vacunas conjugadas de salmonela.
BR112015016817A8 (pt) métodos para derivar um sacarídeo, para conjugar um derivado de sacarídeo e para incitar uma resposta imune em um mamífero, derivado de sacarídeo, conjugado de um derivado de sacarídeo, composição farmacêutica, e, uso de um conjugado ou composição farmacêutica
BR112012023623A2 (pt) agentes osmóticos de polissacarídeos esterificados
MX2016000099A (es) Vacunas sinteticas contra streptococcus pneumoniae tipo 1.
WO2012103444A3 (en) Immunogenic compositions and reagents for preparing
PL391475A1 (pl) Polisacharyd oraz jego pochodne posiadające powinowactwo do fikoliny-3, sposób ich otrzymywania i zastosowania
MX2012008317A (es) Uso prebiotico de polisacarido de soja soluble en agua.
IN2014DN00168A (es)